KRAS and colorectal carcinoma: By screening 2D and 3D cultures of CRC cell lines and PDOs with different KRAS genotype, MS phenotype and molecular subtypes, we demonstrate that the role of RAF1 is independent of KRAS mutational status, MS phenotype and CMS classification.